Bucillamine

CAS: 65002-17-7

Ref. TM-T21334

Produktinformation

• Name: Bucillamine
• Synonyme: DE-019, Thiobutarit, Tiobutarit, SA96, DE 019, DE019, (2R)-2-(2-Methyl-2-sulfanylpropanamido)-3-sulfanylpropanoic acid, (R)-3-Mercapto-2-(2-mercapto-2-methylpropanamido)propanoic acid, <span class="text-smallcaps">L</span>-Cysteine, N-(2-mercapto-2-methyl-1-oxopropyl)-, De 019, N-(2-Mercapto-2-methyl-1-oxopropyl)-<span class="text-smallcaps">L</span>-cysteine, N-(2-Mercapto-2-methylpropanoyl)-<span class="text-smallcaps">L</span>-cysteine, N-(2-Mercapto-2-methylpropionyl)-<span class="text-smallcaps">L</span>-cysteine, N-(2-Mercaptoisobutyryl)cysteine, N-(2-methyl-2-sulfanylpropanoyl)-L-cysteine, N-(2-methyl-2-sulfanylpropanoyl)cysteine, Rimatil, Sa 96, Thiobutarit, Tiobutarit
• CAS: 65002-17-7

Beschreibung

Bucillamine (DE019) protects against Ischemia/reperfusion injury in high-risk organ transplants and inhibits the production of VEGF. Bucillamine is an orally active sulfhydryl donor and antioxidant with antirheumatic and antiangiogenic properties. Bucillamine can be used for studies about choroidal neovascularization and rheumatoid arthritis.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 223.31
• Formel: C₇H₁₃NO₃S₂
• Reinheit: 98%
• Farbe/Form: Solid